跳至主要内容
临床试验/NL-OMON21756
NL-OMON21756已完成不适用

Feasibility of MRI guided focal high-dose-rate brachytherapy for localized prostate cancer.

niversity Medical Center Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age =65 years;
  • 2. Patients with prostate cancer, T stage =T2c, Gleason =7, Prostate Specific Antigen (PSA) <10 ng/ml;
  • 3. Tumour location technically feasible for brachytherapy;
  • 4. Karnofski score =70;
  • 5. Written informed consent;
  • 6. Fit for spinal anaesthesia.

排除标准

  • 1. Previous pelvic radiotherapy for another malignancy;
  • 2. Previous surgery or transurethral resection of the prostate;
  • 3. Prostate cancer recurrence;
  • 4. Patients who meet exclusion criteria for MRI following the protocol of the radiology department of the UMC Utrecht;
  • 5. International Prostate Symptom Score (IPSS) >15;
  • 6. Anticoagulant administration continuously required;
  • 7. Discongruence between prostate biopsies and MR imaging.

研究者

相似试验